For research use only. Not for therapeutic Use.
(R)-(+)-Atenolol is the less active enantiomer of the (R,S)-atenolol. (R,S)-atenolol is a β-adrenergic receptor antagonist[1][2].
| Catalog Number | R050840 |
| CAS Number | 56715-13-0 |
| Synonyms | 2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide |
| Molecular Formula | C14H22N2O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)/t12-/m1/s1 |
| InChIKey | METKIMKYRPQLGS-GFCCVEGCSA-N |
| SMILES | CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O |
| Reference | [1]. Batra S, et al. Bioassay, determination and separation of enantiomers of atenolol by direct and indirect approaches using liquid chromatography: A review. Biomed Chromatogr. 2018 Jan;32(1). [2]. Stoschitzky K, et al. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. Chirality. 1993;5(1):15-9. |
